Editorial: Mutant p53 in Cancer Progression and Personalized Therapeutic Treatments.

Timofeev, Oleg.

Afiliación

Timofeev O; Institute of Molecular Oncology, Universities of Giessen and Marburg Lung Center (UGMLC), Member of the German Center for Lung Research (DZL), Philipps-University, Marburg, Germany.

Front Oncol ; 11: 740578, 2021.

Article en En | MEDLINE | ID: mdl-34458155

Palabras clave

cancer stem cell; metabolic reprogramming; mutant p53; targeted therapy; tumor stroma

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Front Oncol Año: 2021 Tipo del documento: Article